Follow
Pamela R. de Santiago
Pamela R. de Santiago
Postdoctoral fellow
Verified email at upenn.edu
Title
Cited by
Cited by
Year
Beneficial effects of mineralocorticoid receptor blockade in experimental non‐alcoholic steatohepatitis
M Pizarro, N Solís, P Quintero, F Barrera, D Cabrera, ...
Liver International 35 (9), 2129-2138, 2015
652015
Immune-related IncRNA LINC00944 responds to variations in ADAR1 levels and it is associated with breast cancer prognosis
PR de Santiago, A Blanco, F Morales, K Marcelain, O Harismendy, ...
Life Sciences 268, 118956, 2021
352021
ADAR1 Transcriptome editing promotes breast cancer progression through the regulation of cell cycle and DNA damage response
EA Sagredo, AI Sagredo, A Blanco, PR De Santiago, S Rivas, R Assar, ...
Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1867 (8), 118716, 2020
262020
LINE-1 ORF1p as a candidate biomarker in high grade serous ovarian carcinoma
S Sato, M Gillette, PR de Santiago, E Kuhn, M Burgess, K Doucette, ...
Scientific reports 13 (1), 1537, 2023
92023
Increase in ADAR1p110 activates the canonical Wnt signaling pathway associated with aggressive phenotype in triple negative breast cancer cells
F Morales, P Pérez, JC Tapia, L Lobos-González, JM Herranz, F Guevara, ...
Gene 819, 146246, 2022
42022
Total mutational load and clinical features as predictors of the metastatic status in lung adenocarcinoma and squamous cell carcinoma patients
KY Oróstica, J Saez-Hidalgo, PR de Santiago, S Rivas, S Contreras, ...
Journal of Translational Medicine 20 (1), 373, 2022
12022
Disease Causing-Mfn2 Mutations Alter Mitochondrial Fusion and Fission Dynamics in Mouse Embryonic Fibroblast
D Lagos, P Rojas, D Troncoso, B Cartes-Saavedra, R Horvath, V Eisner
Biophysical Journal 120 (3), 350a, 2021
2021
Charcot-Marie-Tooth Type2A Mfn2 Domain-Specific Mutants Deferentially Alter Mitochondrial Fusion Dynamics and Motility
V Eisner, D Troncoso, P Rojas, J Vial, M Castro, S Henríquez, R Horvath
Biophysical Journal 112 (3), 323a-324a, 2017
2017
Role of Fcgamma receptors in experimental Non-Alcoholic Steatohepatitis
D Cabrera, E Jara, R Cruz, N Munoz-Durango, P Rojas de Santiago, ...
HEPATOLOGY 62, 686A-686A, 2015
2015
NFkB inhibition by Andrographolide ameliorates inflammation and fibrogenesis through inflammasome substrate depletion in experimental Non-Alcoholic Steatohepatitis (NASH)
D Cabrera, A Wree, D Povero, N Solis, M Pizarro, P Rojas de Santiago, ...
HEPATOLOGY 62, 685A-685A, 2015
2015
The system can't perform the operation now. Try again later.
Articles 1–10